Customer care
  • Gaviscon 500 + 267mg / 10ml Mint Flavor Oral Suspension 24 Sachets -48%

Gaviscon 500 + 267mg / 10ml Mint Flavor Oral Suspension 24 Sachets

5.71€ 10.90€
  • Purchase 3 items for 5.60€ each
  • Purchase 4 items for 5.48€ each
  • Purchase 5 items for 5.37€ each

Gaviscon 500 + 267mg / 10ml Mint Flavor Oral Suspension

 

Symptomatic treatment of occasional heartburn

 

Active principles

Gaviscon 500mg / 10ml + 267mg / 10ml oral suspension 10 ml contain: Active ingredients: sodium alginate 500 mg sodium bicarbonate 267 mg Excipients: methyl parahydroxybenzoate 40 mg propyl parahydroxybenzoate 6 mg For a full list of excipients, see section 6.1.

 

Excipients

Oral suspension Calcium carbonate; carbomers; methyl parahydroxybenzoate; propyl parahydroxybenzoate; sodium saccharin; fennel flavoring; sodium hydroxide; erythrosine; purified water.

 

Therapeutic indications

Symptomatic treatment of occasional heartburn

 

Contraindications

Hypersensitivity to the active substances or to any of the excipients, including the esters of hydroxybenzoates (parabens). Severe kidney failure.

 

dosage

Oral suspension.Adults and adolescents (12–18 years): 10–20 ml (second – fourth measuring notch or 2–4 measuring spoons or 1– 2 single-dose sachets) after meals and at bedtime. For oral administration. Shake the suspension before use. Special populations Elderly: it is not necessary to change the doses for this age group. Patients with renal insufficiency: the reduced ability to eliminate the exogenous saline supplement provided by antacids with urine can condition potentially severe electrolyte imbalances (see section 4.4).

 

Warnings and Precautions

Do not use for protracted treatments. In patients with very low levels of gastric acid there is a lower possibility of efficacy. In adolescents (12–18 years) use only in cases of real need and under strict medical supervision. In case of renal insufficiency, the medicinal product must be used with caution since the exogenous saline supplement provided by antacids can condition potentially severe electrolyte imbalances. Each 10 ml dose of suspension contains 141 mg (6.2 mmoles) of sodium. This should be taken into consideration in cases where a particularly low-salt diet is recommended, for example in some cases of congestive heart failure and renal impairment. Each 10 ml dose of suspension contains 160 mg (1.6 mmoles) of calcium carbonate. Care should be taken when treating patients with hypercalcaemia, nephrocalcinosis and relapsed kidney stones containing calcium. The tablets contain aspartame, a source of phenylalanine: therefore it should not be taken by patients with phenylketonuria. The suspension contains methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions. Delayed-type reactions (contact dermatitis) generally occur, rarely immediate reactions with urticaria and bronchospasm.

 

Interactions

It is advisable to insert an interval of at least two hours between taking Gaviscon and that of other drugs.

 

Side effects

The following are the side effects of Gaviscon, organized according to the organic systemic classification MedDRA. They are divided by frequency (very common (≥ 1/10), common (≥ 1/100 to ≤ 1/10), uncommon (≥ 1 / 1,000 to ≤ 1/100), rare (≥ 1 / 10,000 to 1 /1,000), very rare (≤ 1 / 10,000)). Gastrointestinal disorders Very rare: flatulence, nausea Skin and subcutaneous tissue disorders Very rare: water retention (edema). Immune system disorders Very rare: allergic manifestations such as urticaria and bronchospasm, ana-phylactic or anaphylactoid reactions. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorization of the medicinal product is important as it allows continuous monitoring of the benefit / risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

 

Pregnancy and breastfeeding

Use in case of real need and under strict medical supervision.

 

Format

Pack of 24 sachets of 10 ml mint flavor (500mg + 267mg)

.